Patients and RWE: Is this the year?

The long-hyped redefinition of healthcare through wearable tech has been … well, long hyped. Early projects, such as Apple HealthKit and Fitbit, were undoubtably important in redefining ‘the possible’ but they haven’t yet achieved transformative application.  Much has been written on why the philosophy that has driven the astonishing success of consumer technology doesn ’t translate to healthcare and when we look at the state of innovation in 2020, many of these structural issues remain.   As Emily Cerciello, Associate Director, Digital Health and Engagement at the Crohn ' s& Colitis Foundation states, “The technology is way ahead of where we are in healthcare, the real challenge is being able to operationalize it. It is more of a logistics bottleneck. All of this needs to catch up, we need to work out who is paying for it and who is leading it for this to be adopted at scale.”  However, when we take a look at the glut of maturing projects within this space, there is reason to think that 2020 could be the year that stasis breaks.   Areas for innovationThe US healthcare industry continues to advance value-based models, changing the structural conditions for wearable innovation. In principle, value-based care requires pharma to deliver efficient R&D, demonstrate value and ensure that medicines have maximum impact. All of the above must be fueled by patient data. The FDA has a big a role to play in both creating demand and enabling supply here, and...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news